Sichuan Hebang Biotechnology Corporation Limited (SHA:603077)
China
· Delayed Price · Currency is CNY 1.770
+0.020 (1.14%)
May 16, 2025, 3:00 PM CST
SHA:603077 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 8,139 | 8,412 | 8,707 | 12,941 | 9,928 | 5,232 | Upgrade
|
| Other Revenue | 135.11 | 135.11 | 117.15 | 97.73 | 59.66 | 29.16 | Upgrade
|
| Revenue | 8,274 | 8,547 | 8,824 | 13,039 | 9,987 | 5,261 | Upgrade
|
| Revenue Growth (YoY) | -1.84% | -3.14% | -32.32% | 30.55% | 89.85% | -11.87% | Upgrade
|
| Cost of Revenue | 7,754 | 8,010 | 6,823 | 7,492 | 5,874 | 4,345 | Upgrade
|
| Gross Profit | 519.76 | 537.18 | 2,001 | 5,547 | 4,113 | 916.12 | Upgrade
|
| Selling, General & Admin | 486.83 | 492.99 | 456.82 | 871.3 | 344.56 | 315.52 | Upgrade
|
| Research & Development | 26.82 | 30.63 | 47.35 | 67.93 | 33.31 | 39.68 | Upgrade
|
| Other Operating Expenses | 66.58 | 63.39 | 60.72 | 110.17 | 89.1 | 43.9 | Upgrade
|
| Operating Expenses | 573.67 | 587.61 | 579.06 | 1,061 | 462.95 | 393.59 | Upgrade
|
| Operating Income | -53.91 | -50.43 | 1,422 | 4,486 | 3,651 | 522.54 | Upgrade
|
| Interest Expense | -78.27 | -66.99 | -24.37 | -51.43 | -77.82 | -82.16 | Upgrade
|
| Interest & Investment Income | 48.29 | 47.05 | 135.57 | 44.52 | 36.31 | 28.04 | Upgrade
|
| Currency Exchange Gain (Loss) | 4.85 | 4.85 | -1.87 | 5.22 | -14.7 | -32.72 | Upgrade
|
| Other Non Operating Income (Expenses) | -6.83 | -5.43 | -10.64 | -1.55 | -14.91 | -9.52 | Upgrade
|
| EBT Excluding Unusual Items | -85.88 | -70.95 | 1,520 | 4,482 | 3,579 | 426.17 | Upgrade
|
| Impairment of Goodwill | - | - | - | -66.07 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -6.56 | -5.67 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 2.32 | 1.04 | 0.69 | 36.99 | -1.23 | 6.67 | Upgrade
|
| Other Unusual Items | 9.9 | 9.9 | 14.91 | 25.31 | 0.2 | -417.03 | Upgrade
|
| Pretax Income | -88.65 | -65.68 | 1,536 | 4,479 | 3,578 | 15.81 | Upgrade
|
| Income Tax Expense | 1.7 | 5.06 | 257.27 | 668.32 | 551.88 | 12.9 | Upgrade
|
| Earnings From Continuing Operations | -90.35 | -70.74 | 1,279 | 3,810 | 3,027 | 2.91 | Upgrade
|
| Minority Interest in Earnings | 104.54 | 102.21 | 4.54 | -3.43 | -8.03 | 38.03 | Upgrade
|
| Net Income | 14.19 | 31.46 | 1,283 | 3,807 | 3,018 | 40.94 | Upgrade
|
| Net Income to Common | 14.19 | 31.46 | 1,283 | 3,807 | 3,018 | 40.94 | Upgrade
|
| Net Income Growth | -98.45% | -97.55% | -66.29% | 26.12% | 7272.47% | -92.08% | Upgrade
|
| Shares Outstanding (Basic) | 8,167 | 8,280 | 8,706 | 8,697 | 8,436 | 8,530 | Upgrade
|
| Shares Outstanding (Diluted) | 9,043 | 8,504 | 8,706 | 8,697 | 8,436 | 8,530 | Upgrade
|
| Shares Change (YoY) | 5.20% | -2.32% | 0.10% | 3.09% | -1.10% | -1.48% | Upgrade
|
| EPS (Basic) | 0.00 | 0.00 | 0.15 | 0.44 | 0.36 | 0.00 | Upgrade
|
| EPS (Diluted) | 0.00 | 0.00 | 0.15 | 0.44 | 0.36 | 0.00 | Upgrade
|
| EPS Growth | -98.53% | -97.49% | -66.32% | 22.33% | 7354.17% | -91.96% | Upgrade
|
| Free Cash Flow | -398.4 | -648.3 | -748.4 | 1,708 | 1,462 | 171.76 | Upgrade
|
| Free Cash Flow Per Share | -0.04 | -0.08 | -0.09 | 0.20 | 0.17 | 0.02 | Upgrade
|
| Dividend Per Share | 0.020 | 0.020 | - | 0.045 | 0.015 | - | Upgrade
|
| Dividend Growth | - | - | - | 200.00% | - | - | Upgrade
|
| Gross Margin | 6.28% | 6.29% | 22.67% | 42.54% | 41.19% | 17.41% | Upgrade
|
| Operating Margin | -0.65% | -0.59% | 16.11% | 34.40% | 36.55% | 9.93% | Upgrade
|
| Profit Margin | 0.17% | 0.37% | 14.54% | 29.20% | 30.22% | 0.78% | Upgrade
|
| Free Cash Flow Margin | -4.81% | -7.58% | -8.48% | 13.10% | 14.64% | 3.26% | Upgrade
|
| EBITDA | 917.39 | 924.25 | 2,410 | 5,400 | 4,282 | 1,165 | Upgrade
|
| EBITDA Margin | 11.09% | 10.81% | 27.31% | 41.41% | 42.87% | 22.15% | Upgrade
|
| D&A For EBITDA | 971.3 | 974.69 | 988.23 | 914.52 | 631.02 | 642.95 | Upgrade
|
| EBIT | -53.91 | -50.43 | 1,422 | 4,486 | 3,651 | 522.54 | Upgrade
|
| EBIT Margin | -0.65% | -0.59% | 16.11% | 34.40% | 36.55% | 9.93% | Upgrade
|
| Effective Tax Rate | - | - | 16.75% | 14.92% | 15.42% | 81.60% | Upgrade
|
| Revenue as Reported | 8,274 | 8,547 | 8,824 | 13,039 | 9,987 | 5,261 | Upgrade
|
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.